The immunotherapy drug pembrolizumab–already FDA-approved for other forms of cancer-has been found to be … – EurekAlert (press release)
Medical Daily |
The immunotherapy drug pembrolizumab–already FDA-approved for other forms of cancer-has been found to be …
EurekAlert (press release) The immunotherapy drug pembrolizumab–already FDA-approved for other forms of cancer-has been found to be effective in patients with metastatic triple negative breast cancer, according to an international clinical trial led by NYU Langone's Perlmutter … Treatment For Triple Negative Breast Cancer; Immunotherapy Drug Effective In New Trials |
